News

Enquanto o presidente americano Donald Trump e seus assessores começam a avaliar substitutos para o presidente do Federal ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
There is always a challenging moment in every investor’s favorite stock and portfolio, especially when said businesses are ...
The Senate has been urged to expedite actions on a Bill to further amend the Administration of Criminal Justice Act (ACJA) to among others, hand the responsibility of implementing non-custodial ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Our writer reveals what he thinks is the most exciting from the four investments he made in his Stocks and Shares ISA last ...
To view videos with matches, highlights & goals, previews, iconic moments and more, visit OneFootball.
The latest news and analysis of the global railway industry from the world's leading international publication.
Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...